Abnova (Taiwan) Corporation - ROE
4133.TW
Price:
$20.2
Market Cap:
$1.22B
Abnova (Taiwan) Corporation specializes in the development and distribution of a comprehensive range of recombinant proteins and antibodies. The company's extensive product portfolio caters to diverse research and diagnostic applications, featuring specialized reagents for SARS-CoV/CoV-2, nucleic acids (both DNA and RNA), and various proteins and peptides. Their offerings further include items like DNAxPab, laboratory beads, dyes, cellular lysates, microscopic slides, antibody pairs and associated kits, as well as antibody and tissue arrays. Additionally, they provide in situ hybridization products, advanced laboratory systems and automation, GMP-grade and analyte-specific reagents, and solu...[Read more]
Industry
Biotechnology
IPO Date
2009-12-28
Stock Exchange
TAI
Ticker
4133.TW
PE Ratio
[-177.66]
ROE
[3.56%]
Current Ratio
[14.57]
Dividend Yield
[0.55%]
Enterprise Value
[834.97M]
Dividend History
The ROE as of September 2026 (TTM) for Abnova (Taiwan) Corporation (4133.TW) is 3.56%
According to Abnova (Taiwan) Corporation’s latest financial reports and current stock price. The company's current ROE is 3.56%. This represents a change of 299.73% compared to the average of 0.89% of the last 4 quarters.
Abnova (Taiwan) Corporation (4133.TW) Historical ROE (quarterly & annually)
How has 4133.TW ROE performed in the past?
The mean historical ROE of Abnova (Taiwan) Corporation over the last ten years is 3.26%. The current 3.56% ROE has changed 9.41% with respect to the historical average. Over the past ten years (40 quarters), 4133.TW's ROE was at its highest in in the September 2022 quarter at 2.16%. The ROE was at its lowest in in the June 2025 quarter at -2.99%.
Average
3.26%
Median
3.58%
Minimum
-0.09%
Maximum
5.79%
Abnova (Taiwan) Corporation (4133.TW) ROE by Quarter and Year
Discovering the peaks and valleys of Abnova (Taiwan) Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.00%
Maximum Annual ROE = 5.79%
Minimum Annual Increase = -101.93%
Minimum Annual ROE = -0.09%
| Year | ROE | Change |
|---|---|---|
| 2025 | -0.09% | -101.93% |
| 2024 | 4.70% | 38.56% |
| 2023 | 3.40% | -41.38% |
| 2022 | 5.79% | 147.44% |
| 2021 | 2.34% | -22.37% |
| 2020 | 3.02% | 1.00% |
| 2019 | 0.27% | -92.72% |
| 2018 | 3.76% | -21.95% |
| 2017 | 4.81% | 5.77% |
| 2016 | 4.55% | 18.24% |
Abnova (Taiwan) Corporation (4133.TW) Average ROE
How has 4133.TW ROE performed in the past?
The current ROE of Abnova (Taiwan) Corporation (4133.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.67%
5-year avg
3.23%
10-year avg
3.26%
Abnova (Taiwan) Corporation (4133.TW) ROE vs. Peers
How is 4133.TW’s ROE compared to its peers?
Abnova (Taiwan) Corporation’s ROE is greater than NaviFUS Corp. (-27.93%), greater than Enimmune corporation (-96.67%), less than BiOptic Inc. (1.92%), less than GenMont Biotech Incorporation (5.32%), greater than GeneReach Biotechnology Corp. (-7.50%), greater than Great Novel Therapeutics Biotech & Medicals (-17.77%), greater than Meribank Biotech Co., Ltd (-11.13%), greater than NeoCore Technology Co., Ltd. (-12.10%), greater than MegaPro Biomedical Co., Ltd (-42.41%), less than Taiwan Advance Bio-Pharmaceutical Inc. (5.69%),
| Company | ROE | Market cap |
|---|---|---|
| -27.93% | $1.63B | |
| -96.67% | $1.21B | |
| 1.92% | $1.09B | |
| 5.32% | $1.36B | |
| -7.50% | $934.03M | |
| -17.77% | $3.82B | |
| -11.13% | $851.31M | |
| -12.10% | $1.25B | |
| -42.41% | $896.43M | |
| 5.69% | $636.30M |
Build a custom stock screener for Abnova (Taiwan) Corporation (4133.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abnova (Taiwan) Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Abnova (Taiwan) Corporation (4133.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Abnova (Taiwan) Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Abnova (Taiwan) Corporation's ROE?
How is the ROE calculated for Abnova (Taiwan) Corporation (4133.TW)?
What is the highest ROE for Abnova (Taiwan) Corporation (4133.TW)?
What is the 3-year average ROE for Abnova (Taiwan) Corporation (4133.TW)?
What is the 5-year average ROE for Abnova (Taiwan) Corporation (4133.TW)?
How does the current ROE for Abnova (Taiwan) Corporation (4133.TW) compare to its historical average?